| Name | Title | Contact Details |
|---|
Health Risk Management, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
MicroMRI is a Langhorne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
US Fitness is constantly growing and improving the fitness experience, and we want you to be part of this revolution! We want passionate, driven individuals who want to spread health and fitness to their communities and are ready to deliver that Ultima...
Bournewood Hospital is a full-service, independent psychiatric hospital licensed for 90 beds, which has been in continuous operation as a psychiatric hospital on twelve acres in South Brookline since 1895